Search results
Buying Buzz: Editas Medicine Inc [EDIT] Director Hopfield Jessica purchases 45,000 shares of the...
Knox Daily· 9 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Editas Medicine Inc shares valued at $253,868 were purchased by Hopfield Jessica on May ...
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
Motley Fool via Yahoo Finance· 7 days agoClinical-stage biotech Editas Medicine (NASDAQ: EDIT) delivered quarterly results that fell well...
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest...
Simply Wall St. via Yahoo Finance· 4 days agoEditas Medicine, Inc. (NASDAQ:EDIT) just released its latest quarterly report and things are not...
Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc (EDIT)
GuruFocus.com via Yahoo Finance· 2 days agoOn May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,000...
Earnings call: Editas Medicine outlines strategic pillars for 2024 By Investing.com
Investing.com· 7 days agoEditas Medicine (NASDAQ:EDIT) has reported significant strides in its first quarter of 2024,...
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
Zacks via Yahoo Finance· 7 days agoEditas Medicine, Inc. EDIT incurred a loss of 76 cents per share in the first quarter of 2024, wider...
Gene Editing Breakthrough: CRISPR Improves Vision in Clinical Trial
SciTechDaily· 3 days agoMass Eye and Ear researchers say their findings support continued research and clinical trials of...
CRISPR can treat common form of inherited blindness, early data hint
Live Science via Yahoo News· 1 day agoA photo shows two male doctors in surgery garb as one preps a long needle for a procedure. A patient...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 6 days agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...